Patrick Lin - Apr 1, 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Apr 1, 2025
Transactions value $
-$1,983
Form type
4
Date filed
4/11/2025, 05:22 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +14.5K +49.84% 43.5K Apr 1, 2025 Direct F1
transaction PCSA Common Stock Tax liability -$1.98K -4.81K -11.06% $0.41 38.7K Apr 1, 2025 Direct
holding PCSA Common Stock 43.5K Apr 1, 2025 Lin Family Trust Feb 4, 2024
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares